Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province.[1] The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.
Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease.[1] The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan.[2]
External links
- http://www.sihuanpharm.com/
References
- Patti Waldmeir and Lucy Hornby. Chinese company develops Ebola treatment Financial Times, 9 October 2014, retrieved 4 January 2015^
- Azusa Nakanishi. Copycats put squeeze on Japanese drugmakers Chicago Tribune, 11 December 2014, retrieved 4 January 2015^